The share price of private hospitals group Mediclinic International, which has a primary listing on the London Stock Exchange and a secondary listing on the JSE, was ailing on Tuesday after an underwhelming interim trading update. The update pencilled in underlying earnings of about 11.5p a share, a drop of 10% compared with the 12.8p reported in the matching period in 2016. Mediclinic shares, which have been under pressure for the past 14 months, touched a 12-month low of R113. Market watchers described the trading update as an understrength dose of numbers when shareholders were desperately keen to see symptoms of a strong recovery.
Would you like to comment on this article?
Sign up (it's quick and free) or sign in now.
Please read our Comment Policy before commenting.
Subscribe now to unlock this article.
Support BusinessLIVE’s award-winning journalism for R129 per month (digital access only).
There’s never been a more important time to support independent journalism in SA. Our subscription packages now offer an ad-free experience for readers.
Cancel anytime.
Questions? Email helpdesk@businesslive.co.za or call 0860 52 52 00. Got a subscription voucher? Redeem it now.